Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€157.25
29.07.22
€200.00
29.07.23
14.87%
30.07.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
29.07.22 90%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€91.39
27.07.22
€100.00
27.07.23
-11.48%
28.07.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
27.07.22 80%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€44.85
27.07.22
€60.00
27.07.23
5.35%
27.07.23

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
gerihouse 
27.07.22 80%
sell
Stratec SE

Start price
Target price
Perf. (%)
€85.00
26.07.22
€66.00
26.07.23
4.94%
06.08.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
kostojunior 
26.07.22 0%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€154.40
23.07.22
€170.00
23.08.22
5.63%
11.08.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
Traumtanz 
23.07.22 70%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€154.40
23.07.22
€170.00
23.08.22
5.63%
11.08.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
Traumtanz 
23.07.22 70%
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€418.20
22.07.22
€550.00
22.07.23
-23.00%
30.05.23

edgaaar 
22.07.22 50%
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€418.20
22.07.22
€550.00
22.07.23
-23.00%
30.05.23

edgaaar 
22.07.22 50%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€155.00
15.07.23
5.64%
23.07.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
Traumtanz 
15.07.22 90%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€155.00
15.07.23
5.64%
23.07.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
Traumtanz 
15.07.22 90%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€175.00
15.07.23
21.16%
16.07.23

maria3 
15.07.22 50%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€175.00
15.07.23
21.16%
16.07.23

maria3 
15.07.22 50%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€235.25
13.07.22
€239.00
13.07.23
-1.59%
13.07.23

francisco20 
13.07.22 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€88.30
13.07.22
€83.00
13.07.23
-11.66%
13.07.23

francisco20 
13.07.22 50%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€469.25
07.07.22
-
07.07.23
-14.35%
07.07.23

Saftman 
07.07.22 50%
sell
Fluidigm Corp.

Start price
Target price
Perf. (%)
€1.68
27.06.22
-
27.06.23
-10.79%
24.04.23

Probably not worthwhile Investment
Lokrim 
27.06.22 20%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.24
24.06.22
€5.00
24.06.23
-1.57%
26.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Marianka 
24.06.22 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.77
10.06.22
€0.20
10.06.23
24.58%
26.06.22

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
dimontalban 
10.06.22 70%
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€49.15
01.06.22
-
01.06.23
-2.34%
11.06.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
kostojunior 
01.06.22 70%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

Prof 
17.05.22 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

Prof 
17.05.22 50%
sell
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.42
15.05.22
-
15.05.23
81.90%
24.04.23

Risky Investment
Lokrim 
15.05.22 20%
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

Maxi_Scalibusa 
06.05.22 50%
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-6.36%
12:23

Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
fabinator 
25.04.22 90%
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-6.36%
12:23

Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
fabinator 
25.04.22 90%